Evidence map›Paper›PMID 32669112›Full record

ArticleAlzheimer's research & therapy2020

Longitudinal changes in EEG power, sleep cycles and behaviour in a tau model of neurodegeneration.

C M Holton, N Hanley, E Shanks, P Oxley, A McCarthy, B J Eastwood, T K Murray, A Nickerson, K A Wafford

Open access · goldAbstract read
In one paragraph

Article in Alzheimer's research & therapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 39 citations in OpenAlex.

  1. Dorsal raphe tau pathology disrupts sleep-wake orchestration and sleep architecture in a sex-specific manner.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

C M HoltonEli Lilly and Company, Erl Wood Manor, Windlesham, Surrey, GU20 6PH, UK.
N HanleyEli Lilly and Company, Erl Wood Manor, Windlesham, Surrey, GU20 6PH, UK.
E ShanksEli Lilly and Company, Erl Wood Manor, Windlesham, Surrey, GU20 6PH, UK.
P OxleyEli Lilly and Company, Erl Wood Manor, Windlesham, Surrey, GU20 6PH, UK.
A McCarthyEli Lilly and Company, Erl Wood Manor, Windlesham, Surrey, GU20 6PH, UK.
B J EastwoodEli Lilly and Company, Erl Wood Manor, Windlesham, Surrey, GU20 6PH, UK.
T K MurrayEli Lilly and Company, Erl Wood Manor, Windlesham, Surrey, GU20 6PH, UK.
A NickersonEli Lilly and Company, Erl Wood Manor, Windlesham, Surrey, GU20 6PH, UK.
K A WaffordEli Lilly and Company, Erl Wood Manor, Windlesham, Surrey, GU20 6PH, UK. kwafford@slowavetx.co.uk.ORCID 0000-0002-8508-4738
Eli Lilly (United Kingdom) · GBEli Lilly (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDisturbed sleep is associated with cognitive decline in neurodegenerative diseases such as Alzheimer's disease (AD) and frontotemporal dementia (FTD). The progressive sequence of how neurodegeneration affects aspects of sleep architecture in conjunction with behavioural changes is not well understood.

methodsWe investigated changes in sleep architecture, spectral power and circadian rhythmicity in the tet-off rTg4510 mouse overexpressing human P301L tau within the same subjects over time. Doxycycline-induced transgene-suppressed rTg4510 mice, tTa carriers and wild-type mice were used as comparators. Spectral power and sleep stages were measured from within the home cage environment using EEG electrodes. In addition, locomotor activity and performance during a T-maze task were measured.

resultsSpectral power in the delta and theta bands showed a time-dependent decrease in rTg4510 mice compared to all other groups. After the initial changes in spectral power, wake during the dark period increased whereas NREM and number of REM sleep bouts decreased in rTg4510 compared to wild-type mice. Home cage locomotor activity in the dark phase significantly increased in rTg4510 compared to wild-type mice by 40 weeks of age. Peak-to-peak circadian rhythm amplitude and performance in the T-maze was impaired throughout the experiment independent of time. At 46 weeks, rTG4510 mice had significant degeneration in the hippocampus and cortex whereas doxycycline-treated rTG4510 mice were protected. Pathology significantly correlated with sleep and EEG outcomes, in addition to locomotor and cognitive measures.

conclusionsWe show that reduced EEG spectral power precedes reductions in sleep and home cage locomotor activity in a mouse model of tauopathy. The data shows increasing mutant tau changes sleep architecture, EEG properties, behaviour and cognition, which suggest tau-related effects on sleep architecture in patients with neurodegenerative diseases.

Indexed as

Tauopathiestau ProteinsAnimalsDisease Models, AnimalElectroencephalographyHumansMiceMice, TransgenicSleeptau ProteinsAlzheimer’s diseaseBehaviourCognitionFrontotemporal dementiaNeurodegenerationPathologyrTg4510SleepSpectral powerTau

Identifiers

PMID32669112
PMCPMC7364634
OpenAlexW3043502524

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.